Jubilant Pharmova Limited
Sunil Singhania, through Abakkus AIF, bought 11 lakh shares of Jubilant Pharmova for ₹100.65 Cr at ₹915.00 apiece in a block deal.
An integrated global pharmaceuticals company, Jubilant Pharmova operates across three core business segments: pharmaceuticals, contract research and development services, and proprietary novel drugs. The company serves domestic and international markets through its diversified portfolio and specialized capabilities in drug development and manufacturing. It combines vertically integrated operations with expertise in custom synthesis and advanced pharmaceutical formulations to address healthcare needs across multiple therapeutic areas.
The man who grew Reliance Mutual Fund's equity AUM from ₹200 Cr to nearly ₹80,000 Cr, one of the greatest fund management runs in Indian history. After leaving Reliance, Sunil Singhania launched Abakkus Asset Management (2018), which now manages ~₹36,700 Cr. Voted Best Fund Manager by Outlook Business (2016 & 2017). First Indian elected to the CFA Institute Board of Governors. His direct disclosed equity portfolio has consistently backed emerging industrials and financials before they became consensus.